Rose has spent her career driving innovation in healthcare, from roles in clinical practice to technology companies. She is committed to finding new ways to leverage technology in delivering better health outcomes.
Prior to Dr.Evidence, Rose was CEO of HealthMyne, a pioneering radiomics company whose IP and technology assets were acquired by Genentech (a Roche company) in 2022. She began her career in nursing at the University of Pittsburgh Medical Center, followed by advancing roles in clinical and care management. Transitioning to leadership in healthcare IT organizations, Higgins took on executive roles with increasing responsibility in organizations including McKesson Corporation and SCIO Health Analytics (acquired by EXL Service Holdings) over a successful 20-year period.
Rose received her Bachelor of Science in Nursing from Duquesne University, and her Master of Public Management from Carnegie Mellon University.